default author photo

David Ritter

University of Cincinnati

SCHOLARLY PAPERS

2

DOWNLOADS

174

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Long-Term Efficacy and Safety of mTOR-Inhibitor Treatmentfor Subependymalgiant-Cellastrocytomain Tuberous Sclerosis

Number of pages: 27 Posted: 24 Apr 2024
Lena-Luise Becker, Karen Agricola, David Ritter, Marguerite Caré, Darcy Krueger and David N. Franz
Charité - Universitätsmedizin Berlin, University of Cincinnati, University of Cincinnati, University of Cincinnati, University of Cincinnati and University of Cincinnati
Downloads 97 (704,534)

Abstract:

Loading...

pediatric neurology, tuberous sclerosis, giant cell astrocytoma, long term use, pediatric oncology, neurocutaneous disorders

2.

Cenobamate's Efficacy for Seizure Treatment in Patients with Tuberous Sclerosis Complex

Number of pages: 15 Posted: 23 Jul 2024
Gewalin Aungaroon, Alexander Cooke, David Ritter, Paul S. Horn, Darcy A. Krueger and David N. Franz
affiliation not provided to SSRN, University of Cincinnati, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, Division of Neurology, affiliation not provided to SSRN and University of Cincinnati
Downloads 77 (823,616)

Abstract:

Loading...

Cenobamate, seizure, epilepsy, treatment, tuberous sclerosis complex